
    
      Objectives

        -  Confirm the safety and effectiveness of the XIENCE V EECSS for the treatment of patients
           in China

        -  Evaluate patient compliance with dual antiplatelet therapy (DAPT)

        -  Evaluate physician-determined XIENCE V EECSS acute performance, deliverability, and
           resource utilization
    
  